Modelling the potential population impact and cost-effectiveness of self-testing for HIV: Evaluation of data requirements

AIDS and Behavior

Volumn 18, Issue SUPPL. 4, 2014, Pages

  Cambiano, Valentina ^a   Mavedzenge, Sue Napierala ^b   Phillips, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RTI INTERNATIONAL   (United States)

Author keywords

Cost effectiveness; Data; HIV; HIV self testing; Modelling

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS; EVALUATION STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; SELF CARE; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; THEORETICAL MODEL;

COST-BENEFIT ANALYSIS; DECISION MAKING; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HIV INFECTIONS; HUMANS; MASS SCREENING; MODELS, THEORETICAL; QUALITY-ADJUSTED LIFE YEARS; RISK REDUCTION BEHAVIOR; SELF CARE; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR;

EID: 84904397233     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0824-x     Document Type: Article

References (62)

1. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352-63.
2. Brinkhof MWG, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. Plos Med. 2009;6(4):e1000066.
3. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446-53. (Pubitemid 41003791)
4. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89(9):1397-405. (Pubitemid 29404565)
5. Efficacy of voluntary. HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet. 2000;356(9224):103- 12.
6. Fonner VA, Denison J, Kennedy CE, O'Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev. 2012;9:CD001224.
7. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):1112-22. (Pubitemid 41735779)
8. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643-56. (Pubitemid 46281312)
9. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657-66.
10. van der Straten A, Van DL, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012;26(7):F13-9.
11. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
12. Staveteig S, Wang S, Head SK, Bradley SEK, Nybro E. Demographic patterns of HIV testing uptake in Sub-Saharan Africa. DHS comparative report 30. Calverton, Maryland, U.S. 2013.
13. WHO/UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. 2007.
14. Report on the first international symposium on self-testing for HIV: The legal, ethical, gender, human rights and public health implications of HIV self-testing scale-up. Geneva, Switzerland. 2013.
15. MacPherson P, Lalloo D, Choko A, van Oosterhout J, Thindwa D, Webb E, et al. Home assessment and initiation of ART following HIV self-testing: a cluster-randomised trial to improve linkage to ART in Blantyre, Malawi [Abstract]. In: 20th Conference on Retroviruses and Opportunistic Infections. 2013.
16. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102.
17. Kalibala S, Tun W, Muraah W, Cherutich P, Oweya E, et al. Knowing myself first': Feasibility of self-testing among health workers in Kenya. Nairobi: Population Council; 2011.
18. Corbett EL. Uptake, accuracy and linkage into care following access to community-based self-testing for HIV in Malawi. 2013.
19. Pant PN, Behlim T, Abrahams L, Vadnais C, Shivkumar S, Pillay S, et al. Will an unsupervised self-testing strategy for HIV work in health care workers of South Africa? A cross sectional pilot feasibility study. PLoS ONE. 2013;8(11):e79772.
20. Lucas A, Armbruster B. The cost-effectiveness of expanded HIV screening in the United States. AIDS. 2013;27(5):795-801.
21. Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health. 2009;6(1):19-33.
22. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-85. (Pubitemid 40204670)
23. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med. 2005;352(6):586-95. (Pubitemid 40204671)
24. Walensky RP, Weinstein MC, Kimmel AD, Seage GR III, Losina E, Sax PE, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118(3):292-300. (Pubitemid 40312641)
25. Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, et al. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One. 2010;5(10):e13132.
26. Venkatesh KK, Becker JE, Kumarasamy N, Nakamura YM, Mayer KH, Losina E, et al. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS ONE. 2013;8(5):e64604.
27. Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, et al. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011;56(1):26-35.
28. Waters RC, Ostermann J, Reeves TD, Masnick MF, Thielman NM, Bartlett JA, et al. A cost-effectiveness analysis of alternative HIV retesting strategies in sub-Saharan Africa. Jaids-J Acquir Immune Defic Syndr. 2011;56(5):443-52.
29. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet. 2000;356(9224):113-21. (Pubitemid 30438512)
30. Katz DA, Cassels SL, Stekler JD. Replacing clinic-based tests with home-use tests may increase HIV prevalence among seattle men who have sex with men: evidence from a mathematical model. Sex Transm Dis. 2014;41(1):2-9.
31. Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, et al. Routine voluntary HIV testing in Durban, South Africa - the experience from an outpatient department. Jaids-J Acquir Immune Defic Syndr. 2007;46(2):181-6. (Pubitemid 47482613)
32. Carballo-Dieguez A, Frasca T, Dolezal C, Balan I. Will gay and bisexually active men at high risk of infection use over-the-counter rapid HIV tests to screen sexual partners? J Sex Res. 2012;49(4):379-87.
33. Lee VJ, Tan SC, Earnest A, Seong PS, Tan HH, Leo YS. User acceptability and feasibility of self-testing with HIV rapid tests. J Acquir Immune Defic Syndr. 2007;45(4):449-53. (Pubitemid 47057673)
34. Ng OT, Chow AL, Lee VJ, Chen MI, Win MK, Tan HH, et al. Accuracy and user-acceptability of HIV self-testing using an oral fluid-based HIV rapid test. PLoS ONE. 2012;7(9):e45168.
35. van Dyk AC. Client-initiated, provider-initiated, or self-testing for HIV: what do South Africans prefer? J Assoc Nurses AIDS Care. 2013;24(6):e45-56.
36. Bilardi JE, Walker S, Read T, Prestage G, Chen MY, Guy R, et al. Gay and bisexual men's views on rapid self-testing for HIV. AIDS Behav. 2013;17(6):2093-9.
37. Greacen T, Friboulet D, Blachier A, Fugon L, Hefez S, Lorente N, et al. Internet-using men who have sex with men would be interested in accessing authorised HIV self-tests available for purchase online. AIDS Care. 2013;25(1):49-54.
38. Carballo-Dieguez A, Frasca T, Balan I, Ibitoye M, Dolezal C. Use of a rapid HIV home test prevents HIV exposure in a high risk sample of men who have sex with men. AIDS Behav. 2012;16(7):1753-60.
39. Choko AT, MacPherson P, Webb EL, Ball H, Sambakunsi R, Mdolo A, et al. One year outcomes following community-based HIV self-testing: a prospective study in Malawi. In: Conference on Retroviruses and Opportunistic Infections. 2014.
40. Pant PN, Bhargava M, Joseph L, Sharma J, Pillay S, Balram B, et al. Will an unsupervised self-testing strategy be feasible to operationalize in Canada? Results from a pilot study in students of a large Canadian university. AIDS Res Treat. 2014;2014:747619.
41. Suthar AB, Ford N, Bachanas PJ, Wong VJ, Rajan JS, Saltzman AK, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10(8):e1001496.
42. Bavinton BR, Brown G, Hurley M, Bradley J, Keen P, Conway DP, et al. Which gay men would increase their frequency of HIV testing with home self-testing? AIDS Behav. 2013;17(6):2084-92.
43. Hoyos J, Belza MJ, Fernandez-Balbuena S, Rosales-Statkus ME, Pulido J, de la Fuente L. Preferred HIV testing services and programme characteristics among clients of a rapid HIV testing programme. BMC Public Health. 2013;13(1):791.
44. Spielberg F, Camp S, Ramachandra E. HIV home self-testing: can it work? [Abstract]. In: National HIV Prevention Conference; 2003.
45. Gaydos CA, Solis M, Hsieh YH, Jett-Goheen M, Nour S, Rothman RE. Use of tablet-based kiosks in the emergency department to guide patient HIV self-testing with a point-of-care oral fluid test. Int J STD AIDS. 2013;24(9):716-21.
46. Spielberg F, Bill and Melinda Gates Foundation. Acceptability of self-testing for STIs in India. 2010.
47. Wright AA, Katz IT. Home testing for HIV. N Engl J Med. 2006;354(5):437-40. (Pubitemid 43200292)
48. Pant PN, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, et al. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(5):373-80.
49. U.S.Food and Drug administration. First rapid home-use HIV kit approved for self-testing. 2012.
50. Gaydos CA, Hsieh YH, Harvey L, Burah A, Won H, Jett-Goheen M, et al. Will patients "opt in" to perform their own rapid HIV test in the emergency department? Ann Emerg Med. 2011;58(1 Suppl 1):S74-8.
51. Asiimwe S, Oloya J, Song X, Whalen CC. Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: a randomized implementation trial. AIDS Behav. 2014.
52. Napierala MS, Baggaley R, Corbett EL. A review of self-testing for HIV: research and policy priorities in a new era of HIV prevention. Clin Infect Dis. 2013;57(1):126-38.
53. Kennedy CE, Fonner VA, Sweat MD, Okero FA, Baggaley R, O'Reilly KR. Provider-initiated HIV testing and counseling in low- and middle-income countries: a systematic review. AIDS Behav. 2012;17(5):1571-90.
54. Ng OT, Tan MT. HIV self-testing: money matters. Clin Infect Dis. 2013;57(5):771-2.
55. Katz DA, Golden MR, Hughes JP, Farquhar C, Stekler JD. Acceptability and ease of use of home self-testing for HIV among MSM [Abstract]. In: 19th Conference on Retroviruses and Opportunistic Infections. 2012.
56. Joint United Nations Programme on HIV AIDS eSFUNCF & WHiG. Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS/a joint UNICEF, UNAIDS, WHO, MSF project. - 6th ed. 2005.
57. Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS. 2011;25(6):843-50.
58. Cambiano V, Bertagnolio S, Jordan MR, Lundgren JD, Phillips A. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. J Infect Dis. 2013;207(Suppl 2):S57-62.
59. Ingole NA, Mehta PR, Bande RN, Paranjpe SM, Wanjare SW. Evaluation of Calypte AWARE HIV-1/2 OMT antibody test as a screening test in an Indian setting. Indian J Med Microbiol. 2010;28(4):295-8.
60. Mayhood MK, Afwamba IA, Odhiambo CO, Ndanu E, Thielman NM, Morrissey AB, et al. Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. J Clin Microbiol. 2008;46(12):3946-51.
61. Alemnji GA, Ngulefac GA, Ndumbe PM, Asonganyi T. Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid. Open AIDS J. 2009;3:14-8.
62. de la Fuente L, Rosales-Statkus ME, Hoyos J, Pulido J, Santos S, Bravo MJ, et al. Are participants in a street-based HIV testing program able to perform their own rapid test and interpret the results? PLoS ONE. 2012;7(10):e46555.